SCOTT PERTILE
**** ********* ******, **********, ** 60564
Cell 630-***-****
Home 630-***-****
************@***.***
Sales Representative/Sales Manager/Product Manager
Bio-Technology - Pharmaceutical Products
Profile
Self motivated, top performing hospital based sales representative with a
proven track record of consistent success. Driven and focused professional
with over 20 years of sales/marketing/management experience. A team
leader; demonstrate outstanding product knowledge, clear understanding of
the sales cycle, relationship building, and coaching/developing
representatives. A competitive professional dedicated to driving business
growth and ROI, very organized with proficient oral and written
communication skills; easy to coach and highly adaptive.
Achievements & Awards
. 1Q 2010 107% Territory attainment
. 4Q 2009 101% Territory attainment
. 1H 2008 District attainment 101%
. 1Q 2008 106% Gliadel attainment
. 2007 Eagle Award Recipient - Achieved 119% Gliadel attainment
. Regional Sales Trainer 2004-05, Field Sales Advisor 2007-08
. 2002 Scios Inc. 114% to plan
. 2001 Scios Inc. 161% to plan; final ranking #28 out of 167 - top 16%
. 1999 Presidents Award recipient for top sales representative in nation
(1 out of 30)
. 1995 Presidents Award for top sales representative in the region (1
out of 60)
Professional Experience
Oncotech / Exiqon Diagnostics, Tustin, CA
September 2009 to present
Oncology Sales Representative
. Responsible for selling an Extreme Drug Resistance (EDR) assay for
chemotherapy resistance to surgical oncologists, medical oncologists,
gynecological oncologists, thoracic surgeons and pathologists.
Territory encompasses approximately 40 hospitals in IL, WI, MN, MO,
KS, NE, ND, SD and IA.
*Eisai, Woodcliff Lake, NJ
December 2003 to August 2009 District Sales Manager,
Neuro-Oncology (May 2008 to August 2009)
. Managed, trained and coached a team of 8 Hospital Sales
Representatives; covered geographical area of 13 states (IL, MI, OH,
IN, KY, TN, MO, NE, IA, SD, MN, NE, KS) with sales responsibility of
~ $13M of Gliadel
. Acquired four peers as Sales Representatives and hired, trained, and
developed four new Hospital Sales Representatives
. Exposure to many well-known Medical and Teaching Hospitals, including
but not limited to, University of Chicago, Ohio State University,
University of Cincinnati, University of Kentucky, University of Iowa,
University of Minnesota, University of Kansas, St. Louis University,
and Indiana University.
. Worked closely with Sales Director and Marketing to learn/develop
strong business acumen, leadership, analytical and problem resolution
skills.
*Eisai - 2 mergers: MGI PHARMA, acquired by Eisai, Guilford
Pharmaceuticals, acquired by MGI Pharma
Executive Territory Manager, (December 2003 to May 2008)
Responsible for selling implantable chemotherapy (Gliadel) wafers to
neurosurgeons neuro-oncologists, medical oncologist and pathologists for
the treatment of advanced brain tumors. Sold Aloxi IV an antiemetic for
the prevention of CINV and Dacogen for the treatment of myelodysplastic
syndrome to medical oncologists and hematologists. Territory encompassed
30 hospitals in IL and Northwest Indiana.
. Sold Aggrastat a GPIIb / IIIa inhibitor to cardiologists and for selling
Gliadel wafers to neurosurgeons, neuro-oncologists, medical oncologist
and pathologists for the treatment of advanced brain tumors.
SCIOS, INC., Mountain View, CA
July 2001 to December 2003
Cardiovascular Sales Specialist
. Launched cardiovascular injectable (Natrecor) to hospital based
cardiologists and emergency room physicians. Successfully placed
Natrecor on formulary at all targeted hospitals (7). Called on both
academic and community hospitals in Chicago.
NYCOMED AMERSHAM, Princeton, NJ
November 1997 to June 2001
Associate Product Manager, Oncology (September 1999-June 2001)
. Responsible for developing the marketing plans for both Metastron,
(metastatic bone pain) and OncoSeed (prostate brachytherapy). Launched
several marketing programs that significantly increased sales and market
share. Worked closely with the Area Sales Managers to ensure
understanding and implementation of key marketing programs.
Oncology Specialist (November 1997 - September 1999)
. Field sales representative in IL, WI, MN. Responsibilities included
selling OncoSeed and Metastron to radiation oncologists, medical
oncologists and urologists.
SANOFI WINTHROP PHARMACEUTICALS, New York, NY
January 1987 to November 1997 Oncology Territory
Representative (April 1, 1996 - November 7, 1997)
. Responsible for launching the new FDA procedure called photodynamic
therapy and the drug used for the procedure, Photofrin, for the treatment
of esophageal cancer. Primary call points included gastroenterologists
and medical oncologists in IL, WI and MI. Set up and coordinated the
training of physicians, nurses and biomedical technicians.
Medical Center Representative (January 1987-March 1996)
. Marketed cardiovascular IV (Inocor, Primacor) to cardiologists,
cardiothoracic surgeons and anesthesiologist as well as diagnostic
imaging agents (Omnipaque) to radiologists, Danocrine for endometriosis
to OB GYNs and analgesics (Talwin NX and Talacen) to orthopedic surgeons
in Chicago.
Education and Training
. Bachelor of Arts in Biology, Augustana College, Rock Island, Illinois
. Varsity baseball team
. Biology Club
Professional Development
. Marketing Strategy Course, University of Chicago Graduate School of
Business (2000)
Certifications
. AORN Operating Room Protocol
. Exposure to Bloodborne Pathogens in the Surgical Environment
. Oncology Preceptorship Program - UTMD Anderson Cancer Center (1996)
. Anesthesiology O.R. Rotation - University of Miami Miller School of
Medicine (2009)